127 related articles for article (PubMed ID: 29952486)
1. [In process].
Vollmer H
Med Monatsschr Pharm; 2017 Mar; 40(3):131. PubMed ID: 29952486
[No Abstract] [Full Text] [Related]
2. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
[No Abstract] [Full Text] [Related]
3. [Clinicotherapeutic studies on a new hepatobiliary capsule preparation].
Medgyesi G
Med Welt; 1966 Jul; 31():1623-6. PubMed ID: 5929031
[No Abstract] [Full Text] [Related]
4. [Trials with dibilene therapy].
Bénazet C; Breton J
J Med Bord; 1965 May; 142(5):859-67. PubMed ID: 5830455
[No Abstract] [Full Text] [Related]
5. The effect of ursodeoxycholic acid in cystic cholangiopathies.
Lammert F; Méndez-Sánchez N
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):949-950. PubMed ID: 27740534
[No Abstract] [Full Text] [Related]
6. [On the treatment of hepatobiliary diseases with phytopharmaceutics].
Glitsch HW
Hippokrates; 1965 Sep; 36(18):726-9. PubMed ID: 5324310
[No Abstract] [Full Text] [Related]
7. [The effect of cholerelics on bile flow in diseases of the liver and of the bile ducts (author's transl)].
Bode JC; Strohmeyer G
Leber Magen Darm; 1974 Apr; 4(2):65-71. PubMed ID: 4828906
[No Abstract] [Full Text] [Related]
8. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
Alenezi B; Lamoureux E; Alpert L; Szilagyi A
Dig Dis Sci; 2005 Jan; 50(1):196-200. PubMed ID: 15712660
[No Abstract] [Full Text] [Related]
9. Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review.
Cheng K; Ashby D; Smyth R
J R Soc Med; 1997; 90 Suppl 31(Suppl 31):6-12. PubMed ID: 9204005
[No Abstract] [Full Text] [Related]
10. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
Serfaty L; Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
[No Abstract] [Full Text] [Related]
11. [Alpha-(1-hydroxy-4-phenylcyclohexyl)-butyric acid, a synthetic choleretic. Pharmacology, clinical aspects and review considerations on the experience of a few years of systematic use of the choleretic alone or in combination with other substances in hepatocholecystic syndromes].
Barbi G
Minerva Gastroenterol; 1966; 12(2):64-7. PubMed ID: 5960468
[No Abstract] [Full Text] [Related]
12. [Cholagogic agents].
Pasichnyk IKh
Farm Zh; 1978; (2):39-43. PubMed ID: 658339
[No Abstract] [Full Text] [Related]
13. [Usefulness of ursodeoxycholic acid in a case of hepatic sarciodosis].
Saito A; Takano M; Kaise S; Utsumi Y; Gunji N; Ishihata R; Irisawa A; Ohira H
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):632-8. PubMed ID: 20379098
[TBL] [Abstract][Full Text] [Related]
14. Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
Schmidt HH; Manns MP
Am J Gastroenterol; 1996 Feb; 91(2):406-7. PubMed ID: 8607528
[No Abstract] [Full Text] [Related]
15. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
16. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
Lebensztejn DM
Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
[TBL] [Abstract][Full Text] [Related]
17. [New aspects of pharmacological effects of ursodeoxycholic acid].
Radchenko VG; Seliverstov PV; Sitkin SI
Eksp Klin Gastroenterol; 2014; (8):4-10. PubMed ID: 25911905
[TBL] [Abstract][Full Text] [Related]
18. [Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].
Grigor'eva GA; Meshalkina NIu
Eksp Klin Gastroenterol; 2013; (6):3-6. PubMed ID: 24772851
[No Abstract] [Full Text] [Related]
19. [The substantiation of UDCA usage in functional disorders of biliary tract].
Il'chenko AA
Eksp Klin Gastroenterol; 2011; (9):108-12. PubMed ID: 22629786
[TBL] [Abstract][Full Text] [Related]
20. [Bile acids in norm and pathology].
Il'chenko AA
Eksp Klin Gastroenterol; 2010; (4):3-13. PubMed ID: 20623947
[No Abstract] [Full Text] [Related]
[Next] [New Search]
